SEI Investments’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $18.7M | Buy |
76,462
+6,398
| +9% | +$1.39M | 0.02% | 839 |
|
|
2026
Q1 | $11.8M | Buy |
70,064
+22,464
| +47% | +$3.88M | 0.01% | 1040 |
|
|
2025
Q4 | $8.69M | Sell |
47,600
-527
| -1% | -$73.6K | 0.01% | 1121 |
|
|
2025
Q3 | $5.85M | Buy |
48,127
+4,178
| +10% | +$471K | 0.01% | 1240 |
|
|
2025
Q2 | $4.59M | Buy |
43,949
+8,220
| +23% | +$870K | 0.01% | 1304 |
|
|
2025
Q1 | $4.17M | Sell |
35,729
-12,501
| -26% | -$1.42M | 0.01% | 1342 |
|
|
2024
Q4 | $4.08M | Sell |
48,230
-131
| -0.3% | -$12K | 0.01% | 1389 |
|
|
2024
Q3 | $4.35M | Buy |
48,361
+7,737
| +19% | +$675K | 0.01% | 1354 |
|
|
2024
Q2 | $3.27M | Buy |
40,624
+4,970
| +14% | +$368K | ﹤0.01% | 1410 |
|
|
2024
Q1 | $2.85M | Buy |
35,654
+2,697
| +8% | +$226K | ﹤0.01% | 1464 |
|
|
2023
Q4 | $2.62M | Sell |
32,957
-28,178
| -46% | -$1.88M | ﹤0.01% | 1480 |
|
|
2023
Q3 | $4.27M | Sell |
61,135
-123,132
| -67% | -$9.2M | 0.01% | 1240 |
|
|
2023
Q2 | $13.2M | Buy |
184,267
+60,158
| +48% | +$4.44M | 0.02% | 726 |
|
|
2023
Q1 | $7.66M | Sell |
124,109
-13,358
| -10% | -$878K | 0.01% | 986 |
|
|
2022
Q4 | $10.6M | Sell |
137,467
-11,322
| -8% | -$677K | 0.02% | 707 |
|
|
2022
Q3 | $6.64M | Sell |
148,789
-13,797
| -8% | -$689K | 0.01% | 947 |
|
|
2022
Q2 | $6.23M | Buy |
162,586
+16,223
| +11% | +$513K | 0.01% | 990 |
|
|
2022
Q1 | $6.06M | Buy |
146,363
+1,909
| +1% | +$59.2K | 0.01% | 1005 |
|
|
2021
Q4 | $5.46M | Sell |
144,454
-1,338
| -0.9% | -$49.2K | 0.01% | 1089 |
|
|
2021
Q3 | $4.81M | Sell |
145,792
-388
| -0.3% | -$15.1K | 0.01% | 1102 |
|
|
2021
Q2 | $9.86M | Buy |
146,180
+2,010
| +1% | +$121K | 0.02% | 741 |
|
|
2021
Q1 | $8.16M | Buy |
144,170
+33,649
| +30% | +$2.37M | 0.02% | 767 |
|
|
2020
Q4 | $9M | Buy |
110,521
+29,098
| +36% | +$2.18M | 0.02% | 687 |
|
|
2020
Q3 | $5.8M | Buy |
81,423
+28,796
| +55% | +$2.24M | 0.02% | 802 |
|
|
2020
Q2 | $4.33M | Sell |
52,627
-1,088
| -2% | -$83.7K | 0.01% | 929 |
|
|
2020
Q1 | $3.16M | Buy |
53,715
+21,432
| +66% | +$1.75M | 0.01% | 959 |
|
|
2019
Q4 | $3.34M | Buy |
32,283
+9,535
| +42% | +$385K | 0.01% | 1104 |
|
|
2019
Q3 | $460K | Sell |
22,748
-4,910
| -18% | -$126K | ﹤0.01% | 1931 |
|
|
2019
Q2 | $712K | Sell |
27,658
-15,987
| -37% | -$320K | ﹤0.01% | 1720 |
|
|
2019
Q1 | $621K | Buy |
+43,645
| New | +$405K | ﹤0.01% | 1777 |
|
Other funds holding AXSM
DTC
SEI Investments's AXSM Position: Q2 2026 in Review
SEI Investments increased its Axsome Therapeutics (AXSM) stake by 9.1% in Q2 2026, buying an estimated $1.39M and bringing the position to 76,462 shares worth $18.7M. The position accounts for 0.02% of the portfolio, ranked #839.
SEI Investments first reported a position in AXSM in Q1 2019 and has held it in 30 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.
- SEI Investments held 76,462 shares of Axsome Therapeutics worth $18.7M as of Q2 2026.
- SEI Investments bought 6,398 Axsome Therapeutics shares in Q2 2026, an estimated $1.39M.
- Axsome Therapeutics made up 0.02% of SEI Investments's portfolio in Q2 2026, its #839 holding.
- SEI Investments first reported a position in Axsome Therapeutics in Q1 2019 and has held it in 30 quarters since.
- 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.
Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.